# The Medicines (Products for Human Use-Fees) Regulations 2008, Paragraph 2: Calculation of turnover


(1) Subject to sub-paragraph (2), “turnover” means, for the purposes of calculating the periodic fee payable in connection with the holding of a marketing authorization for a relevant fee period, the gross value at manufacturer’s prices of all medicinal products to which the authorization relates which are sold or supplied in the United Kingdom by the holder of the authorization during the period of 12 months preceding the commencement of the relevant fee period.
(2) For the purposes of calculating the periodic fee payable in connection with the holding of marketing authorizations mentioned in Part 4 of this Schedule for a relevant fee period, the quantity of products taken for the purposes of sub-paragraph (1) is the aggregate of all the products to which the authorizations relate.

---
Source: https://www.legislation.gov.uk/uksi/2008/552/schedule/3/paragraph/2 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2008/schedule-3/paragraph-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.